Full-year 2017 Financial Results
-
Financial
Kuros Biosciences Reports Full-Year 2017 Results
Financial highlights CHF 17.0 million cash at year-end CHF 16.9 million equity raise in June 2017 Standby equity facility established…
Read More » -
Financial
SpineGuard Reports Full-Year 2017 Financial Results
March 15, 2018 PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Regulatory News: SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that develops and markets…
Read More »